This compound is primarily utilized in the field of pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of certain drugs targeting neurological disorders, including depression and anxiety. Its structural properties make it suitable for binding to specific receptors in the brain, aiding in the modulation of neurotransmitter activity. Additionally, it is explored for its potential in developing treatments for chronic pain and other central nervous system-related conditions. Researchers also investigate its application in creating enantiomerically pure compounds, which are crucial for ensuring the efficacy and safety of chiral drugs.